Current management of hepatocellular carcinoma: an Eastern perspective. - Wikidata - awgldk - TriplyDB

Current management of hepatocellular carcinoma: an Eastern perspective.

Current management of hepatocellular carcinoma: an Eastern perspective.

http://www.wikidata.org/entity/Q38410816

about

Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study.Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma.The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinoma Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma.Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance.Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma

P2860

Q33758258-A760E30E-8B60-4357-8B22-110F50367FC4 Q37073766-F3F9ED06-313E-4182-85CF-73D6A6796185 Q37108804-5506CCDE-199F-4D37-BE27-0AE3F3DF645D Q37242795-3D1F7A33-D84C-45BA-9A4A-04C0F8296C62 Q38635603-5B4CAC30-E318-4713-AFA9-491CBDD50E43 Q40846805-BB18F9DC-A6FC-4DEC-AEA4-BE0415ED7CAA Q42679004-E159F8B0-97D5-4ECF-BEFF-5D48D952FB3A Q47225007-0D2E6DD6-2CDF-479F-838A-D835E3ACEC3C Q52595227-F579ECB4-914C-4A89-92D6-DF96D5B8DA63 Q55065541-EA772ACF-8375-4DB3-8A4D-AAF58820CBCC Q58768575-384B18F0-856C-4421-8D55-4C8C7D916C42

P2860

Current management of hepatocellular carcinoma: an Eastern perspective.

http://www.wikidata.org/entity/Q38410816

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Current management of hepatocellular carcinoma: an Eastern perspective.

@en

type

label

Current management of hepatocellular carcinoma: an Eastern perspective.

@en

prefLabel

Current management of hepatocellular carcinoma: an Eastern perspective.

@en

P1433

Q38410816-5E2F7B49-06FC-4EC3-B70A-5F41BD405723

P1476

Q38410816-4877E0EA-CD47-4234-95CD-88309FC321F4

P2093

Q38410816-39CD91F1-71F2-46D8-81FC-9D819FB726B9

Q38410816-A40BDD1D-E210-40F0-9C81-D57344E276F4

Q38410816-C217EE09-A880-45FD-B4C0-BFF9425A013A

P2860

Q38410816-03B77C79-0AD0-4192-88D4-F4E7F88562C7

Q38410816-04E9F954-F32E-4BB8-9F59-9F02D02F6863

Q38410816-068F7A48-18A9-485B-AAAA-BDB4B6F09DFF

Q38410816-08589F5B-50DD-42FA-9751-95EB73993DD4

Q38410816-08DBDC9C-2ABA-40D1-9191-709B3E301189

Q38410816-10A2ED41-9F15-4AFF-B9E3-0E4542E44549

Q38410816-10D81557-7171-449A-AEFA-36D94DA3FF13

Q38410816-12137F0F-54BD-451D-BD8E-7587D69F8690

Q38410816-122D152D-DF8C-4EE6-9CC2-77BBFBEE4E99

Q38410816-19C9E2C1-A160-435A-BF50-D0D5EB663C30

P304

Q38410816-518F3960-852D-452F-8F37-E01A5803A941

P31

Q38410816-588EC035-6297-4DE1-8B3D-0C7E07554179

P356

Q38410816-DFD83A0C-6240-4313-B982-4CED507564A7

P407

Q38410816-A7FC6046-CAFC-45C0-B4FD-A230274C322B

P433

Q38410816-74F6BEAD-9DE8-4B61-815F-68D60EC59354

P478

Q38410816-BC4FEEBD-8B9D-44E7-9BE1-7A2EF8FD879D

P577

Q38410816-51F36007-C232-4111-98BF-833E07F545FB

P5875

Q38410816-D4C972B6-AD5F-4A63-8698-E3A30D0EFA80

P698

Q38410816-1ADFD34D-94AB-4348-B657-47C549A4ABD3

P932

Q38410816-78953E7D-6D80-4A7D-86F9-01993E4D3642

P356

WJG.V21.I13.3826

P1433

World Journal of Gastroenterology

P1476

Current management of hepatocellular carcinoma: an Eastern perspective.

@en

P2093

Hyung Joon Yim

http://www.w3.org/2001/XMLSchema#string

Sang Jun Suh

http://www.w3.org/2001/XMLSchema#string

Soon Ho Um

http://www.w3.org/2001/XMLSchema#string

P2860

Liver transplantation for hepatocellular carcinoma

Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

P304

3826-3842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I13.3826

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274728057

http://www.w3.org/2001/XMLSchema#string

P698

25852267

http://www.w3.org/2001/XMLSchema#string

P932

4385529

http://www.w3.org/2001/XMLSchema#string